• SiteOne Therapeutics Receives NIH Grant americanpharmaceuticalreview
    September 27, 2018
    SiteOne Therapeutics announced the company has been awarded a $1.4 million, two-year, Phase 2 SBIR grant from the National Eye Institute (NEI), a member of the US National Institutes of Health (NIH).
PharmaSources Customer Service